90 related articles for article (PubMed ID: 2576359)
1. Study of potential kinetic interactions of picumast dihydrochloride and theophylline in vitro and after oral administration in man.
Wittenbrink-Dix AM; Neugebauer G; Fuhr U; Neubert P; Besenfelder E; Woelke-Seidl E; Harder S; Staib AH
Arzneimittelforschung; 1989 Oct; 39(10A):1339-43. PubMed ID: 2576359
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of picumast dihydrochloride and its active metabolites M1 and M2 in humans.
Neugebauer G; Wittenbrink-Dix AM; Woelke-Seidl E; Kaufmann B; Ponton T; Dahmen W; Mosberg H; Nieder N; Besenfelder E
Arzneimittelforschung; 1989 Oct; 39(10A):1336-9. PubMed ID: 2576358
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of picumast dihydrochloride in patients with liver cirrhosis.
Neugebauer G; Raedsch R; Stiehl A; Kaufmann B; Besenfelder E; Neubert P; Walter-Sack I
Arzneimittelforschung; 1989 Oct; 39(10A):1343-7. PubMed ID: 2576360
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of picumast after administration of 14C-picumast dihydrochloride in dogs, rats, rabbits and monkeys.
Schaumann W; Besenfelder E; Boehm E; Neubert P; Roesch A; Sterz H
Arzneimittelforschung; 1989 Oct; 39(10A):1321-7. PubMed ID: 2576356
[TBL] [Abstract][Full Text] [Related]
5. A one-year double-blind clinical study of the efficacy and tolerability of picumast dihydrochloride versus ketotifen in patients with bronchial asthma.
Slapke J; Müller S; Boerner D
Arzneimittelforschung; 1989 Oct; 39(10A):1368-72. PubMed ID: 2576366
[TBL] [Abstract][Full Text] [Related]
6. Antiallergic activity of picumast dihydrochloride in several animal species.
Roesch A; Schaumann W; Wilhelms OH
Arzneimittelforschung; 1989 Oct; 39(10A):1310-6. PubMed ID: 2576354
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of picumast dihydrochloride in comparison with placebo in asthmatic patients.
Boerner D; Metz K; Eberhardt R
Arzneimittelforschung; 1989 Oct; 39(10A):1363-7. PubMed ID: 2576365
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of picumast after administration of picumast dihydrochloride and antiallergic activity of the main metabolites.
Besenfelder E; Neubert P; Roesch A; Schaumann W; Wilhelms OH
Arzneimittelforschung; 1989 Oct; 39(10A):1317-20. PubMed ID: 2576355
[TBL] [Abstract][Full Text] [Related]
9. Effect of picumast dihydrochloride on antigen-induced early and late airway responses in allergic sheep.
Abraham WM
Arzneimittelforschung; 1989 Oct; 39(10A):1328-31. PubMed ID: 2576357
[TBL] [Abstract][Full Text] [Related]
10. Double-blind multicenter controlled clinical study comparing the efficacy of picumast dihydrochloride versus astemizole and placebo in patients with seasonal allergic rhinitis.
Franke W; Messinger D
Arzneimittelforschung; 1989 Oct; 39(10A):1360-3. PubMed ID: 2576364
[TBL] [Abstract][Full Text] [Related]
11. A placebo-controlled comparison of the efficacy and tolerability of picumast dihydrochloride and terfenadine in patients with seasonal allergic rhinitis.
Boerner D; Metz K; Eberhardt R; Schürmann W
Arzneimittelforschung; 1989 Oct; 39(10A):1356-9. PubMed ID: 2576363
[TBL] [Abstract][Full Text] [Related]
12. Double-blind study on the influence of picumast dihydrochloride on safety-related performance.
Herberg KW
Arzneimittelforschung; 1989 Oct; 39(10A):1348-51. PubMed ID: 2576361
[TBL] [Abstract][Full Text] [Related]
13. Acceptability, safety and efficacy of picumast dihydrochloride on long-term use in patients with perennial bronchial asthma.
Boerner D; Metz K; Eberhardt R
Arzneimittelforschung; 1989 Oct; 39(10A):1372-4. PubMed ID: 2576367
[TBL] [Abstract][Full Text] [Related]
14. Influence of picumast dihydrochloride on the ex vivo histamine release from leucocytes of allergic asthmatic patients.
Zimmermann I; Roesch A; Ulmer WT
Arzneimittelforschung; 1989 Oct; 39(10A):1351-3. PubMed ID: 2483313
[TBL] [Abstract][Full Text] [Related]
15. Double-blind controlled crossover study comparing the protective effect of picumast dihydrochloride versus placebo following nasal allergen challenge.
Franke W; Bachert C; Messinger D
Arzneimittelforschung; 1989 Oct; 39(10A):1354-6. PubMed ID: 2576362
[TBL] [Abstract][Full Text] [Related]
16. Picumast dihydrochloride (Auteral), a new anti-allergic inhibitor of mediator release and action.
Wilhelms OH; Roesch A; Schaumann W
Agents Actions Suppl; 1991; 34():335-49. PubMed ID: 1686528
[TBL] [Abstract][Full Text] [Related]
17. Study on the absolute bioavailability of quinine and theophylline from tablets after single dose oral administration as compared to intravenous infusion in healthy male non-smoking volunteers.
Fuder H; Herzog R; Vaupel W; Wetzelsberger N; Lücker PW
Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):651-60. PubMed ID: 7746027
[TBL] [Abstract][Full Text] [Related]
18. Chemical synthesis of picumast dihydrochloride.
Witte EC
Arzneimittelforschung; 1989 Oct; 39(10A):1309. PubMed ID: 2576353
[TBL] [Abstract][Full Text] [Related]
19. Influence of morning or evening administration on absorption of theophylline.
Su YM; Cheng TP; Yeh TW; Wen CY; Wang DI
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):113-8. PubMed ID: 10677921
[TBL] [Abstract][Full Text] [Related]
20. Loratadine and terfenadine interaction with nefazodone: Both antihistamines are associated with QTc prolongation.
Abernethy DR; Barbey JT; Franc J; Brown KS; Feirrera I; Ford N; Salazar DE
Clin Pharmacol Ther; 2001 Mar; 69(3):96-103. PubMed ID: 11240972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
